Feed PRQR
PR
ProQR Therapeutics N.V.
PRQR · NASDAQ
$1.81 -3.72% (-$0.07)
1M +6.47%
Market Cap 165.0M €
P/E Ratio -
Div. Yield -
ROE 65.63%
Valuation
31 /100
Expensive P/S 10.80x
P/B 3.34x
P/E N/A
Growth
78 /100
Growing Rev. growth 61.99%
Book val. growth 9.72%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 83.01%
Net margin 265.21%
Op. margin 275.92%
Quality
2 /100
Poor ROIC 49.78%
ROE 65.63%
ROA 35.95%
Debt
69 /100
Low Debt/Equity 0.28x
Current ratio 3.09x
Int. coverage -48.66x
Stability
16 /100
Unstable Beta 0.03x
Rev. volatility 104.73%
EPS volatility 38.80%
Întreabă StockBot despre PRQR
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Daniel Anton de Boer
Employees
166
Headquarters
Leiden
Evenimente viitoare
05 NOV.
Earnings
Upcoming earnings report